BioSpace Scraper - Biotech & Pharma Jobs

{
  "searchQueries": [
    "clinical research associate",
    "medical writer"
  ],
  "maxResults": 30,
  "maxResultsPerQuery": 10,
  "includeJobDetails": true,
  "maxConcurrency": 3,
  "includeCompanyDetails": true
}

{
  "id": "3081505",
  "title": "Principal Scientist - Cancer Early Detection",
  "job_url": "https://jobs.biospace.com/job/3081505/principal-scientist-cancer-early-detection",
  "company_name": "InVitro Cell Research, LLC",
  "company_logo_url": "https://assets.biospace.com/public/logos/2216621",
  "company_profile_url": "https://www.biospace.com/employer/2216621/invitro-cell-research-llc",
  "company_address": null,
  "company_phone": null,
  "company_type": "biotech",
  "company_website": "http://www.invitrocellresearch.com/",
  "company_careers_url": null,
  "company_about": "InVitro Cell Research, LLC (ICR) is a privately funded company focused on regenerative and preventive personalized medicine. We are dedicated to discovering and developing interventions to slow and reverse biological aging and prevent major age-related diseases.\n\nICR has a small-group vibe and a highly collaborative work environment. We invest in our scientists, providing them the state-of-the-art resources they need to leverage their time and skills most effectively, empowering small teams to accomplish the amazing and advance our mission.\n\nOur mission is to research ways to repair aging people, fast.",
  "company_headquarters": "Englewood, New Jersey",
  "company_social_urls": null,
  "industry": "Biotechnology",
  "location": "Englewood, New Jersey",
  "country": "US",
  "city": "Englewood",
  "region": "New Jersey",
  "employment_type": "Full-time",
  "remote_option": "onsite",
  "salary_min": 165000,
  "salary_max": 165000,
  "salary_currency": "USD",
  "salary_period": "annual",
  "salary_text": "USD 165,000 per year",
  "description_snippet": "ICR's Cancer Early Detection program is focused on building early warning systems out of arrays of blood- and urine-based biomarkers from cancer patients and healthy controls, focusing on early stage cancers. We're using machine learning to predict cancer signatures to enable early intervention w...",
  "description_full": "ICR's Cancer Early Detection program is focused on building early warning systems out of arrays of blood- and urine-based biomarkers from cancer patients and healthy controls, focusing on early stage cancers. We're using machine learning to predict cancer signatures to enable early intervention when cancer is most treatable. We're hiring a Principal Scientist to lead our Cancer Early Detection Team.\n\nWith ICR, you'll get to:\n\nLead a cutting-edge cancer biomarkers group with the goal of detecting cancer at its earliest stages\nContribute highly practical and readily translatable pan-cancer screening/early detection, diagnostic, prevention and therapeutic ideas\nQuantify and track cancer biomarkers, including CTCs, cfDNA, serum, plasma, and urine proteins, RNA, metabolites, driver-gene mutations, epigenetic modifications, etc\nCollaborate with ICR's Biomarkers Team to perform molecular and cellular cancer prevention screening assays, under a personalized medicine paradigm\n\nPlease apply if you have:\n\nA PhD, MD or both\nAt least 10 years of cancer research experience, preferably in early detection and biomarkers\nCurrent and in-depth knowledge of pan-cancer: screening, early detection, biomarkers, diagnostic prediction, genetics, prevention, and chemical and vaccine-therapeutics (practical and experimental)\nProgramming experience in Python\nSolid grasp of biostatistics, especially probability theory\nExperience with prediction modeling and machine learning, including experience using proper scoring rules\n\nIdeally, you'll also have:\n\nExpert knowledge and understanding of worldwide cancer biomarker and detection assay development pipelines\nExperience with cell-based assays, immunofluorescent microscopy, qPCR, flow cytometry, single-cell genomics, RNAseq, cell culture, organoid culture, Illumina NextSeq 550, DNA methylation sequencing, ddPCR, Luminex, clinical chemistry instrumentation, Kryptor, Access 2, robotic liquid handling (e.g. Tecan), Vortex, and DepArray\nExperience with protein, RNA, and small metabolite cancer biomarker analysis\nEven if you don't meet all of these criteria, please apply anyway\n\nAnd you'll need:\n\nAn easygoing, friendly personality\nThe ability to work in the United States without sponsorship\n\nSalary\n\nStarting base pay range: $165,000/yr - $215,000/yr\n\nStarting additional compensation range: $7,500/yr - $20,000/yr\n\nStarting position title and compensation are commensurate with experience.",
  "description_html": "<p>ICR's Cancer Early Detection program is focused on building early warning systems out of arrays of blood- and urine-based biomarkers from cancer patients and healthy controls, focusing on early stage cancers. We're using machine learning to predict cancer signatures to enable early intervention when cancer is most treatable. We're hiring a <strong>Principal Scientist</strong> to lead our Cancer Early Detection Team.</p><p><strong>With ICR, you'll get to:</strong></p><ul><li><p>Lead a cutting-edge cancer biomarkers group with the goal of detecting cancer at its earliest stages</p></li><li><p>Contribute highly practical and readily translatable pan-cancer screening/early detection, diagnostic, prevention and therapeutic ideas</p></li><li><p>Quantify and track cancer biomarkers, including CTCs, cfDNA, serum, plasma, and urine proteins, RNA, metabolites, driver-gene mutations, epigenetic modifications, etc</p></li><li><p>Collaborate with ICR's Biomarkers Team to perform molecular and cellular cancer prevention screening assays, under a personalized medicine paradigm</p></li></ul><p><strong>Please apply if you have:</strong></p><ul><li><p>A PhD, MD or both</p></li><li><p>At least 10 years of cancer research experience, preferably in early detection and biomarkers</p></li><li><p>Current and in-depth knowledge of pan-cancer: screening, early detection, biomarkers, diagnostic prediction, genetics, prevention, and chemical and vaccine-therapeutics (practical and experimental)</p></li><li><p>Programming experience in Python</p></li><li><p>Solid grasp of biostatistics, especially probability theory</p></li><li><p>Experience with prediction modeling and machine learning, including experience using proper scoring rules</p></li></ul><p><strong>Ideally, you'll also have:</strong></p><ul><li><p>Expert knowledge and understanding of worldwide cancer biomarker and detection assay development pipelines</p></li><li><p>Experience with cell-based assays, immunofluorescent microscopy, qPCR, flow cytometry, single-cell genomics, RNAseq, cell culture, organoid culture, Illumina NextSeq 550, DNA methylation sequencing, ddPCR, Luminex, clinical chemistry instrumentation, Kryptor, Access 2, robotic liquid handling (e.g. Tecan), Vortex, and DepArray</p></li><li><p>Experience with protein, RNA, and small metabolite cancer biomarker analysis</p></li><li><p>Even if you don't meet all of these criteria, please apply anyway</p></li></ul><p><strong>And you'll need:</strong></p><ul><li><p>An easygoing, friendly personality</p></li><li><p>The ability to work in the United States without sponsorship</p></li></ul><h2>Salary</h2><p><strong>Starting</strong> <strong>base pay range:</strong> $165,000/yr - $215,000/yr</p><p><strong>Starting additional compensation range:</strong> $7,500/yr - $20,000/yr</p><p>Starting position title and compensation are commensurate with experience.</p>",
  "description_md": "ICR's Cancer Early Detection program is focused on building early warning systems out of arrays of blood- and urine-based biomarkers from cancer patients and healthy controls, focusing on early stage cancers. We're using machine learning to predict cancer signatures to enable early intervention when cancer is most treatable. We're hiring a **Principal Scientist** to lead our Cancer Early Detection Team.\n\n**With ICR, you'll get to:**\n\n- Lead a cutting-edge cancer biomarkers group with the goal of detecting cancer at its earliest stages\n\n- Contribute highly practical and readily translatable pan-cancer screening/early detection, diagnostic, prevention and therapeutic ideas\n\n- Quantify and track cancer biomarkers, including CTCs, cfDNA, serum, plasma, and urine proteins, RNA, metabolites, driver-gene mutations, epigenetic modifications, etc\n\n- Collaborate with ICR's Biomarkers Team to perform molecular and cellular cancer prevention screening assays, under a personalized medicine paradigm\n\n**Please apply if you have:**\n\n- A PhD, MD or both\n\n- At least 10 years of cancer research experience, preferably in early detection and biomarkers\n\n- Current and in-depth knowledge of pan-cancer: screening, early detection, biomarkers, diagnostic prediction, genetics, prevention, and chemical and vaccine-therapeutics (practical and experimental)\n\n- Programming experience in Python\n\n- Solid grasp of biostatistics, especially probability theory\n\n- Experience with prediction modeling and machine learning, including experience using proper scoring rules\n\n**Ideally, you'll also have:**\n\n- Expert knowledge and understanding of worldwide cancer biomarker and detection assay development pipelines\n\n- Experience with cell-based assays, immunofluorescent microscopy, qPCR, flow cytometry, single-cell genomics, RNAseq, cell culture, organoid culture, Illumina NextSeq 550, DNA methylation sequencing, ddPCR, Luminex, clinical chemistry instrumentation, Kryptor, Access 2, robotic liquid handling (e.g. Tecan), Vortex, and DepArray\n\n- Experience with protein, RNA, and small metabolite cancer biomarker analysis\n\n- Even if you don't meet all of these criteria, please apply anyway\n\n**And you'll need:**\n\n- An easygoing, friendly personality\n\n- The ability to work in the United States without sponsorship\n\n## Salary\n\n**Starting** **base pay range:** $165,000/yr - $215,000/yr\n\n**Starting additional compensation range:** $7,500/yr - $20,000/yr\n\nStarting position title and compensation are commensurate with experience.",
  "posted_at_datetime": "2026-10-01T16:00:55.942Z",
  "posted_at_text": "Oct 1, 2026",
  "expires_at": "2026-10-31",
  "apply_url": "https://jobs.biospace.com/job/3081505/principal-scientist-cancer-early-detection",
  "external_apply_url": null,
  "direct_apply": true,
  "discipline": "Science/R&D, Biotechnology, Immunology, Oncology",
  "career_level": "senior",
  "therapy_area": "oncology",
  "required_education": "Doctorate/PHD/MD",
  "hotbed": "Pharm Country",
  "security_clearance": null,
  "search_query": "scientist",
  "source_platform": "biospace.com",
  "scraped_at": "2026-10-01T17:42:29Z",
  "company": "InVitro Cell Research, LLC",
  "source_url": "https://jobs.biospace.com/job/3081505/principal-scientist-cancer-early-detection",
  "posted_at": "2026-10-01"
}

https://mcp.apify.com?tools=santamaria-automations/biospace-scraper